38 related articles for article (PubMed ID: 2649227)
1. Immunohistochemical evaluation of hormone receptors with predictive value in mammary carcinomas.
Pleşan DM; Georgescu CV; Ciobotea S; Pătrană N; Mitroi L; Pleşan C
Curr Health Sci J; 2009 Jul; 35(3):184-9. PubMed ID: 24778819
[TBL] [Abstract][Full Text] [Related]
2. Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.
Zhou T; Li Y; Yang L; Tang T; Zhang L; Shi J
Biomed Res Int; 2017; 2017():2603685. PubMed ID: 28497041
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of angiogenesis by Chalkley counting in node negative cancer of the ampulla of Vater.
Park JS; Kim HK; Hong SW; Kim JK; Yoon DS
J Korean Med Sci; 2012 May; 27(5):495-9. PubMed ID: 22563213
[TBL] [Abstract][Full Text] [Related]
4. Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.
Masmoudi H; Hewitt SM; Petrick N; Myers KJ; Gavrielides MA
IEEE Trans Med Imaging; 2009 Jun; 28(6):916-25. PubMed ID: 19164073
[TBL] [Abstract][Full Text] [Related]
5. Triple-negative breast cancer and obesity in a rural Appalachian population.
Vona-Davis L; Rose DP; Hazard H; Howard-McNatt M; Adkins F; Partin J; Hobbs G
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3319-24. PubMed ID: 19064545
[TBL] [Abstract][Full Text] [Related]
6. Biological features of premalignant disease in the human breast.
Allred DC; Mohsin SK
J Mammary Gland Biol Neoplasia; 2000 Oct; 5(4):351-64. PubMed ID: 14973381
[TBL] [Abstract][Full Text] [Related]
7. Multicentric Breast Carcinoma: Evaluation of Clinicopathological and Immunohistochemical Characteristics.
Arihiro K; Kaneko M; Suehiro SI; Yamamoto A; Kurihara K; Takeda S; Kuroi K; Toge T; Inai K
Breast Cancer; 1996 Dec; 3(3):181-198. PubMed ID: 11091756
[TBL] [Abstract][Full Text] [Related]
8. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion.
Vakkala M; Pääkkö P; Soini Y
Br J Cancer; 1999 Oct; 81(4):592-9. PubMed ID: 10574243
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
10. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.
Toikkanen S; Pylkkänen L; Joensuu H
Br J Cancer; 1997; 76(9):1234-40. PubMed ID: 9365176
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; Clark GM; McGuire WL
Breast Cancer Res Treat; 1993 Oct; 28(1):9-20. PubMed ID: 8123871
[TBL] [Abstract][Full Text] [Related]
12. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
[TBL] [Abstract][Full Text] [Related]
13. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).
Schairer C; Byrne C; Keyl PM; Brinton LA; Sturgeon SR; Hoover RN
Cancer Causes Control; 1994 Nov; 5(6):491-500. PubMed ID: 7827235
[TBL] [Abstract][Full Text] [Related]
14. Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma.
Helin H; Isola J; Helle M; Koivula T
Br J Cancer; 1990 Jul; 62(1):109-12. PubMed ID: 2202418
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of progesterone receptors in paraffin wax sections of breast carcinoma.
Soomro S; Shousha S
J Clin Pathol; 1990 Aug; 43(8):671-4. PubMed ID: 2169484
[TBL] [Abstract][Full Text] [Related]
16. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
Leers MP; Nap M
Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.
Helin HJ; Helle MJ; Helin ML; Isola JJ
Am J Clin Pathol; 1988 Aug; 90(2):137-42. PubMed ID: 2456008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
